Ao Ospedali Riuniti Marche Nord

Pesaro 61122

0 studies enrolling now · 2 studies all time

What they study most

Gastric, or Gastroesophageal Junction Adenocarcinoma, Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations

Studies at this site

• Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML — Completed
• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed